Related references
Note: Only part of the references are listed.Establishment of an in vitro safety assessment model for lipid-lowering drugs using same-origin human pluripotent stem cell-derived cardiomyocytes and endothelial cells
Xuan Ni et al.
ACTA PHARMACOLOGICA SINICA (2022)
Endoplasmic Reticulum Stress-Mediated p62 Downregulation Inhibits Apoptosis via c-Jun Upregulation
Wenjun Yu et al.
BIOMOLECULES & THERAPEUTICS (2021)
UFBP1, a key component in ufmylation, enhances drug sensitivity by promoting proteasomal degradation of oxidative stress-response transcription factor Nrf2
Zhanhong Hu et al.
ONCOGENE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Improved Proteomics-Based Drug Mechanism-of-Action Studies Using 16-Plex Isobaric Mass Tags
Nico Zinn et al.
JOURNAL OF PROTEOME RESEARCH (2021)
USP7 Inhibition Alleviates H2O2-Induced Injury in Chondrocytes via Inhibiting NOX4/NLRP3 Pathway
Gang Liu et al.
FRONTIERS IN PHARMACOLOGY (2021)
Quantitative Interactomics of Lck-TurboID in Living Human T Cells Unveils T Cell Receptor Stimulation-Induced Proximal Lck Interactors
Xien Yu Chua et al.
JOURNAL OF PROTEOME RESEARCH (2021)
RNF6 promotes myeloma cell proliferation and survival by inducing glucocorticoid receptor polyubiquitination
Ying Ren et al.
ACTA PHARMACOLOGICA SINICA (2020)
The E3 ubiquitin ligase STUB1 attenuates cell senescence by promoting the ubiquitination and degradation of the core circadian regulator BMAL1
Kifayat Ullah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex
Dirksen E. Bussiere et al.
NATURE CHEMICAL BIOLOGY (2020)
NADPH protects against kainic acid-induced excitotoxicity via autophagy-lysosome pathway in rat striatum and primary cortical neurons
Zi-Qi Liu et al.
TOXICOLOGY (2020)
Proximity labeling in mammalian cells with TurboID and split-TurboID
Kelvin F. Cho et al.
NATURE PROTOCOLS (2020)
Pharmacological activation of REV-ERBα represses LPS-induced microglial activation through the NF-κB pathway
Dong-kai Guo et al.
ACTA PHARMACOLOGICA SINICA (2019)
Proximity-dependent biotinylation mediated by TurboID to identify protein-protein interaction networks in yeast
Marc Larochelle et al.
JOURNAL OF CELL SCIENCE (2019)
SILAC Quantitative Proteomics and Biochemical Analyses Reveal a Novel Molecular Mechanism by Which ADAM12S Promotes the Proliferation, Migration, and Invasion of Small Cell Lung Cancer Cells through Upregulating Hexokinase 1
Qianqian Duan et al.
JOURNAL OF PROTEOME RESEARCH (2019)
Mebendazole elicits potent antimyeloma activity by inhibiting the USP5/c-Maf axis
Xue-han Chen et al.
ACTA PHARMACOLOGICA SINICA (2019)
Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance
Matthew Pech et al.
ELIFE (2019)
Structural Basis and Kinetic Pathway of RBM39 Recruitment to DCAF15 by a Sulfonamide Molecular Glue E7820
Xinlin Du et al.
STRUCTURE (2019)
Aryl Sulfonamides Degrade RBM39 and RBM23 by Recruitment to CRL4-DCAF15
Tabitha C. Ting et al.
CELL REPORTS (2019)
The emerging role for Cullin 4 family of E3 ligases in tumorigenesis
Ji Cheng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
The PRIDE database and related tools and resources in 2019: improving support for quantification data
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2019)
Cereblon suppresses the lipopolysaccharide-induced inflammatory response by promoting the ubiquitination and degradation of c-Jun
Jing Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Efficient proximity labeling in living cells and organisms with TurboID
Tess C. Branon et al.
NATURE BIOTECHNOLOGY (2018)
Selective degradation of splicing factor CAPERα by anticancer sulfonamides
Taisuke Uehara et al.
NATURE CHEMICAL BIOLOGY (2017)
Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15
Ting Han et al.
SCIENCE (2017)
Meet the neighbors: Mapping local protein interactomes by proximity-dependent labeling with BioID
Renata Varnaite et al.
PROTEOMICS (2016)
A Human Interactome in Three Quantitative Dimensions Organized by Stoichiometries and Abundances
Marco Y. Hein et al.
CELL (2015)
The BioPlex Network: A Systematic Exploration of the Human Interactome
Edward L. Huttlin et al.
CELL (2015)
Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma
Yuan Xiao Zhu et al.
BLOOD (2014)
Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN
Anita K. Gandhi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Cancer-relevant Splicing Factor CAPERα Engages the Essential Splicing Factor SF3b155 in a Specific Ternary Complex
Sarah Loerch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Gang Lu et al.
SCIENCE (2014)
Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatment
Yoichi Ozawa et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Heterocyclic compounds as carbonic anhydrase inhibitor
Asif Husain et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2012)
Affinity-purification coupled to mass spectrometry: Basic principles and strategies
Wade H. Dunham et al.
PROTEOMICS (2012)
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen
J Moffat et al.
CELL (2006)
E7070: a novel synthetic sulfonamide targeting the cell cycle progression for the treatment of cancer
C van Kesteren et al.
ANTI-CANCER DRUGS (2002)
E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivo
Y Ozawa et al.
EUROPEAN JOURNAL OF CANCER (2001)
Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells
K Fukuoka et al.
INVESTIGATIONAL NEW DRUGS (2001)
Share Paper
